Pharmafile Logo

Glaucoma in perspective

Double win at Communiqué 2016: Pegasus scoops awards for Consultancy of the Year (for the second time!) and Excellence in Media Relations

Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have won the prestigious Consultancy of the Year award at the 2016 Communiqué Awards in London. The judges...

Inizio

Gilead Sciences

Gilead’s hepatitis C sales start to slide – the question is how quickly?

CEO anticipates eventual “equilibrium” through shift toward treatment of less severely ill patients

- PMLiVE

Celgene disappointed as Revlimid fails lymphoma trial

Study shows improvement in progression-free survival but no overall survival rate benefit

- PMLiVE

FCB Health takes home network prize at the Creative Floor Awards

And GSK wins Best Healthcare Company at advertising ceremony

- PMLiVE

BMS appoints oncology development head

Dr Fouad Namouni promoted from head of medical

- PMLiVE

Evolve or die

How brand teams can bring more value to their customers

- PMLiVE

Austrian project raises dementia awareness through art

Aims to challenge and reframe societal understandings of dementia

- PMLiVE

Cheil moves into health with wethepeople London joint venture

Launches healthcare division with the specialist UK agency

Beyond Andrology: Trends in Men’s Health in Emerging Markets

Published in eyeforpharma July 2016 by Rachel Howard

Inizio

- PMLiVE

Brain training ‘could cut dementia risk’, says study

Findings suggest computerised speed of processing training can reduce cognitive decline by 48 percent

- PMLiVE

Claire Gillis to lead European operations as ghg restructures

Will be the healthcare comms group's executive managing director, Europe

Boehringer Ingelheim headquarters

Boehringer stops Gilotrif head and neck cancer trials

Trial data suggests the drug is “highly unlikely” to prolong patients’ remission

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links